The company was founded in 1999 and is one of the earliest enterprises engaged in the development and manufacture of interventional cardiac devices in China. The company has always focused on providing a full range of services for cardiovascular patients, driving high-quality development through innovation, and has now become a leading domestic cardiovascular health industry platform. As an overall solution provider for the entire life cycle in the field of cardiovascular diseases, the company's business segments are divided into medical devices, pharmaceuticals, medical services and health management. The company's main products include cardiovascular implantation, in vitro diagnosis, surgical anesthesia, APIs and preparations, medical services and health management.